Compare PDSB & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PDSB | MBBC |
|---|---|---|
| Founded | 2005 | 1902 |
| Country | United States | United States |
| Employees | 10 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.5M | 33.5M |
| IPO Year | 2015 | N/A |
| Metric | PDSB | MBBC |
|---|---|---|
| Price | $0.56 | $13.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 323.6K | 2.1K |
| Earning Date | 05-13-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $47.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.52 | $9.94 |
| 52 Week High | $1.90 | $14.64 |
| Indicator | PDSB | MBBC |
|---|---|---|
| Relative Strength Index (RSI) | 33.24 | 57.16 |
| Support Level | N/A | $12.84 |
| Resistance Level | $1.16 | N/A |
| Average True Range (ATR) | 0.06 | 0.29 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 14.60 | 64.09 |
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.